National Cancer Institute Surveillance. Epidemiology, and end results program. Cancer stat facts: Colorectal Cancer. SEER website. National Institutes of Health. https://seer.cancer.gov/statfacts/html/colorect.htmlFeburary 20, 2023.Accessed.
2.
Van der GeestLGLam-BoerJKoopmanMVerhoefCElferinkMAGde WiltJHW. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015;32(5):457-465.
3.
Foxtrot Collaborative G. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012;13(11):1152-1160.
4.
KarouiMRullierALucianiA, et al.Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22-ECKINOXE trial. BMC Cancer. 2015;15:511.
5.
ArredondoJBaixauliJPastorC, et al.Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery. Clin Transl Oncol. 2017;19(3):379-385.
6.
BensonABVenookAPAl-HawaryMM, et al.Colon Cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2021;19(3):329-359.
7.
LiskaDStocchiLKaragkounisG, et al.Incidence, patterns, and predictors of locoregional recurrence in Colon Cancer. Ann Surg Oncol. 2017;24(4):1093-1099.
8.
O'ConnellMJCampbellMEGoldbergRM, et al.Survival following recurrence in stage II and III Colon Cancer: findings from the accent data set. J Clin Oncol. 2008;26(14):2336-2341.
9.
BastiaenenVPAalbersAGJArjona-SánchezA, et al.Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: an international multicentre cohort study. Eur J Surg Oncol. 2021;47(9):2405-2413.
10.
MacariDKawakSRaofiVWasvaryHJaiyesimiI. Recurrence pattern and outcomes in T4 colon cancer: a single institution analysis. J Surg Oncol. 2020;121(2):337-341.
11.
SanoffHK. Improving treatment approaches for rectal cancer. N Engl J Med. 2022;386(25):2425-2426.
12.
JiangSFagmanJBMaY, et al.A comprehensive review of pancreatic cancer and its therapeutic challenges. Aging (Albany NY). 2022;14(18):7635-7649.
13.
BolgerJCDonohoeCLLoweryMReynoldsJV. Advances in the curative management of oesophageal cancer. Br J Cancer. 2022;126(5):706-717.
14.
GroupCS. A comparison of laparoscopically assisted and open colectomy for Colon Cancer. N Engl J Med. 2004;350(20):2050-2059.
15.
LacyAMGarcía-ValdecasasJCDelgadoS, et al.Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet. 2002;359(9325):2224-2229.
16.
JayneDGGuillouPJThorpeH, et al.Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol. 2007;25(21):3061-3068.
17.
VogelJDFelderSIBhamaAR, et al.The american society of colon and rectal surgeons clinical practice guidelines for the management of Colon Cancer. Dis Colon Rectum. 2022;65(2):148-177.
18.
PaquetteIMSwensonBRKwaanMRMellgrenAFMadoffRD. Thirty-day outcomes in patients treated with en bloc colectomy and pancreatectomy for locally advanced carcinoma of the Colon. J Gastrointest Surg. 2012;16(3):581-586.
19.
Colon Cancer Laparoscopic or Open Resection Study GroupBuunenMVeldkampR, et al.Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 2009;10(1):44-52.
20.
BagshawPFAllardyceRAFramptonCM, et al.Long-term outcomes of the australasian randomized clinical trial comparing laparoscopic and conventional open surgical treatments for colon cancer: the Australasian Laparoscopic Colon Cancer study trial. Ann Surg. 2012;256(6):915-919.
21.
HorseyMLSparksADLaiDHerur-RamanANgMObiasV. Surgical management of splenic flexure colon cancer: a retrospective propensity-matched study comparing open and minimally invasive approaches using the national cancer database. Int J Colorectal Dis. 2021;36(12):2739-2747.
22.
GreenBLMarshallHCCollinsonF, et al.Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg. 2013;100(1):75-82.
23.
DuanB-SZhaoG-HYangHWangY. A pooled analysis of robotic versus laparoscopic surgery for Colon Cancer. Surg Laparosc Endosc Percutan Tech. 2016;26(6):523-530.
24.
SheetzKHNortonECDimickJBRegenbogenSE. Perioperative outcomes and trends in the use of robotic colectomy for medicare beneficiaries from 2010 through 2016. JAMA Surg. 2020;155(1):41-49.
25.
FeinbergAEChesneyTRAcunaSASammourTQuereshyFA. Oncologic outcomes following laparoscopic versus open resection of pt4 colon cancer: a systematic review and meta-analysis. Dis Colon Rectum. 2017;60(1):116-125.
26.
ChenPZhouHChenCQianXYangLZhouZ. Laparoscopic vs. open colectomy for T4 colon cancer: a meta-analysis and trial sequential analysis of prospective observational studies. Front Surg. 2022;9:1006717.
27.
ParascandolaSAHorseyMLHotaS, et al.Surgical resection of T4 colon cancers: an NCDB propensity score-matched analysis of open, laparoscopic, and robotic approaches. J Robot Surg. 2021;15(5):701-710.
28.
BlikkendaalMDTwijnstraARStiggelboutAMBeerlageHPBemelmanWAJansenFW. Achieving consensus on the definition of conversion to laparotomy: a Delphi study among general surgeons, gynecologists, and urologists. Surg Endosc. 2013;27(12):4631-4639.
29.
YangCWexnerSDSafarB, et al.Conversion in laparoscopic surgery: does intraoperative complication influence outcome?Surg Endosc. 2009;23(11):2454-2458.
30.
CasillasSDelaneyCPSenagoreAJBradyKFazioVW. Does conversion of a laparoscopic colectomy adversely affect patient outcome?Dis Colon Rectum. 2004;47(10):1680-1685.
31.
RottoliMStocchiLGeislerDPKiranRP. Laparoscopic colorectal resection for cancer: effects of conversion on long-term oncologic outcomes. Surg Endosc. 2012;26(7):1971-1976.
32.
HealdRJHusbandEMRyallRD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?Br J Surg. 1982;69(10):613-616.
33.
WiegeringAIsbertCDietzUA, et al.Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades. BMC Cancer. 2014;14(1):816.
34.
KöckerlingFReymondMAAltendorf-HofmannADworakOHohenbergerW. Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol. 1998;16(1):324-329.
35.
KimSHBaeKBKimJM, et al.Oncologic outcomes and risk factors for recurrence after tumor-specific mesorectal excision of Rectal Cancer: 782 Cases. J Korean Soc Coloproctol. 2012;28(2):100-107.
HohenbergerWWeberKMatzelKPapadopoulosTMerkelS. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcome. Colorectal Dis. 2009;11(4):354-364.
38.
KimNKKimYWHanYD, et al.Complete mesocolic excision and central vascular ligation for colon cancer: principle, anatomy, surgical technique, and outcomes. Surg Oncol. 2016;25(3):252-262.
39.
StorliKESøndenaaKFurnesB, et al.Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-II. Tech Coloproctol. 2014;18(6):557-564.
40.
CraneJHamedMBoruckiJPEl-HadiAShaikhIStearnsAT. Complete mesocolic excision versus conventional surgery for colon cancer: a systematic review and meta-analysis. Colorectal Dis. 2021;23(7):1670-1686.
41.
De SimoniOBarinaASommarivaA, et al.Complete mesocolic excision versus conventional hemicolectomy in patients with right colon cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2021;36(5):881-892.
42.
MazzarellaGMuttilloEMPicardiBRossiSMuttilloIA. Complete mesocolic excision and D3 lymphadenectomy with central vascular ligation in right-sided colon cancer: a systematic review of postoperative outcomes, tumor recurrence and overall survival. Surg Endosc. 2021;35(9):4945-4955.
43.
AdaminaMManwaringMLParkK-JDelaneyCP. Laparoscopic complete mesocolic excision for right colon cancer. Surg Endosc. 2012;26(10):2976-2980.
44.
DewulfMKalmarAVandenberkB, et al.Complete mesocolic excision does not increase short-term complications in laparoscopic left-sided colectomies: a comparative retrospective single-center study. Langenbeck's Arch Surg. 2019;404(5):557-564.
45.
BertelsenCANeuenschwanderAUJansenJE, et al.5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study. Lancet Oncol. 2019;20(11):1556-1565.
46.
GaoZWangCCuiY, et al.Efficacy and safety of complete mesocolic excision in patients with Colon Cancer: three-year results from a prospective, nonrandomized, double-blind, controlled trial. Ann Surg. 2020;271(3):519-526.
47.
XuLSuXHeZ, et al.Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial. Lancet Oncol. 2021;22(3):391-401.
48.
Di BuonoGBuscemiSCocorulloG, et al.Feasibility and safety of laparoscopic complete mesocolic excision (CME) for right-sided Colon Cancer: short-term outcomes. A randomized clinical study. Ann Surg. 2021;274(1):e894-e895.
49.
ParkIJChoiGSKangBMLimKHJunSH. Lymph node metastasis patterns in right-sided colon cancers: is segmental resection of these tumors oncologically safe?Ann Surg Oncol. 2009;16(6):1501-1506.
50.
YamaokaYKinugasaYShiomiA, et al.The distribution of lymph node metastases and their size in colon cancer. Langenbeck's Arch Surg. 2017;402(8):1213-1221.
51.
ShiozawaMUenoHShiomiA, et al.Study protocol for an international prospective observational cohort study for optimal bowel resection extent and central radicality for Colon Cancer (T-REX study). Jpn J Clin Oncol. 2021;51(1):145-155.
52.
CunninghamDAllumWHStenningSP, et al.Perioperative chemotherapy versus surgery alone for resectable Gastroesophageal Cancer. N Engl J Med. 2006;355(1):11-20.
53.
SauerRBeckerHHohenbergerW, et al.Preoperative versus postoperative Chemoradiotherapy for Rectal Cancer. N Engl J Med. 2004;351(17):1731-1740.
54.
MortonDSeymourMMagillL, et al.Preoperative Chemotherapy for operable Colon Cancer: mature results of an international randomized controlled trial. J Clin Oncol. 2023;41(8):1541-1552.
55.
DehalAGraff-BakerANVuongB, et al.Neoadjuvant Chemotherapy improves survival in patients with clinical T4b Colon Cancer. J Gastrointest Surg. 2018;22(2):242-249.
56.
CheongCKNistalaKRYNgCH, et al.Neoadjuvant therapy in locally advanced colon cancer: a meta-analysis and systematic review. J Gastrointest Oncol. 2020;11(5):847-857.
57.
ChalabiMFanchiLFDijkstraKK, et al.Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020;26(4):566-576.
58.
DigheSSwiftIBrownG. CT staging of colon cancer. Clin Radiol. 2008;63(12):1372-1379.
59.
DigheSSwiftIMagillL, et al.Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience. Colorectal Dis. 2012;14(4):438-444.
60.
GosaviRChiaCMichaelMHeriotAGWarrierSKKongJC. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2021;36(10):2063-2070.
61.
de GooyerJMVerstegenMGt Lam-BoerJ, et al.Neoadjuvant chemotherapy for locally advanced T4 Colon Cancer: a nationwide propensity-score matched cohort analysis. Dig Surg. 2020;37(4):292-301.
62.
KarouiMGalloisCPiessenG, et al.Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high-risk Stage II and III colon cancers? Three years' follow-up results of the PRODIGE 22 phase II randomized multicentre trial. Colorectal Dis. 2021;23(6):1357-1369.
63.
SeymourMTMortonDobotIFT Investigators. FOxTROT: an international randomised controlled trial in 1052 patients (pts) evaluating neoadjuvant chemotherapy (NAC) for colon cancer. J Clin Oncol. 2019;37(15_suppl l):3504.
64.
BensonAB3rdVenookAPCederquistL, et al.Colon Cancer, version 1.2017, NCCN clinical practice guidelines in Oncology. J Natl Compr Cancer Netw. 2017;15(3):370-398.
65.
ArredondoJPastorESimóV, et al.Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review. Tech Coloproctol. 2020;24(10):1001-1015.
66.
JakobsenAAndersenFFischerA, et al.Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial. Acta Oncol. 2015;54(10):1747-1753.
67.
Hospital KNU. Neoadjuvant FOLFOX Chemotherapy for patients with locally advanced Colon Cancer. National Library of Medicine. https://ClinicalTrials.gov/show/NCT03426904March 13, 2023.Accessed.
68.
University SY-s. Neoadjuvant FOLFOXIRI versus immediate surgery for stage II and III Colon Cancers. National Library of Medicine. https://ClinicalTrials.gov/show/NCT05194878 March 13, 2023.Accessed.
69.
University SY-s. Neoadjuvant treatment with mFOLFOXIRI Plus Cadonilimab (AK104) versus mFOLFOX6 in locally advanced Colorectal Cancer (OPTICAL-2). National Library of Medicine. https://ClinicalTrials.gov/show/NCT05571644March 13, 2023.Accessed.
70.
León Ud. Analysis of the effectiveness of Neoadjuvant Chemotherapy in the treatment of Colon Cancer Locally Advanced (ELECLA) (ELECLA). National Library of Medicine. Accessed March 13, 2023.https://ClinicalTrials.gov/show/NCT04188158
71.
Neoadjuvant Chemotherapy versus standard treatment in patients with locally advanced Colon Cancer. Hospital Vejle: National Library of Medicine. Accessed March 13, 2023.https://ClinicalTrials.gov/show/NCT01918527
72.
KanamotoTMatsukiMOkudaJ, et al.Preoperative evaluation of local invasion and metastatic lymph nodes of colorectal cancer and mesenteric vascular variations using multidetector-row computed tomography before laparoscopic surgery. J Comput Assist Tomogr. 2007;31(6):831-839.
73.
DigheSPurkayasthaSSwiftI, et al.Diagnostic precision of CT in local staging of colon cancers: a meta-analysis. Clin Radiol. 2010;65(9):708-719.
74.
FernandezLMParladeAJWasserEJ, et al.How Reliable Is CT Scan in staging right Colon Cancer?Dis Colon Rectum. 2019;62(8):960-964.
75.
HunterCSiddiquiMGeorgiou DelisleT, et al.CT and 3-T MRI accurately identify T3c disease in colon cancer, which strongly predicts disease-free survival. Clin Radiol. 2017;72(4):307-315.
76.
LiuLHLvHWangZCRaoSXZengMS. Performance comparison between MRI and CT for local staging of sigmoid and descending colon cancer. Eur J Radiol. 2019;121:108741.
77.
RafaelsenSRDamCVagn-HansenC, et al.CT and 3 Tesla MRI in the TN staging of Colon Cancer: A prospective, blind study. Curr Oncol. 2022;29(2):1069-1079.
78.
ParkSYChoSHLeeMA, et al.Diagnostic performance of MRI- versus MDCT-categorized T3cd/T4 for identifying high-risk stage II or stage III colon cancers: a pilot study. Abdom Radiol (NY). 2019;44(5):1675-1685.
79.
RollvénEHolmTGlimeliusBLörincEBlomqvistL. Potentials of high resolution magnetic resonance imaging versus computed tomography for preoperative local staging of colon cancer. Acta Radiol. 2013;54(7):722-730.
80.
DumanMTasSMecitEA, et al.Preoperative local staging of colorectal cancer patients with MDCT. Hepato-Gastroenterology. 2012;59(116):1108-1112.
